SILENCE THERAPEUTICS PLC News

Express News | Silence Therapeutics PLC : Morgan Stanley Raises Target Price to $49.00 From $45.00

ReutersJun 28 07:26 ET

Express News | Silence Therapeutics PLC: Divesiran Was Well Tolerated

ReutersJun 27 07:31 ET

Express News | Silence Therapeutics: Divesiran Eliminated Need for Phlebotomy in All Well-Controlled Patients Following Infrequent Dosing

ReutersJun 27 07:31 ET

Express News | Silence Therapeutics Announces Positive Results From Ongoing Sanreco Phase 1 Study of Divesiran in Polycythemia Vera Patients

ReutersJun 27 07:30 ET

Express News | Silence Therapeutics: Study Demonstrated Highly Significant and Sustained Reductions in LP(a) to Week 48

ReutersJun 20 07:31 ET

Express News | Silence Therapeutics Announces Positive Topline 48-Week Data From Phase 2 Study of Zerlasiran in Patients With Elevated Lipoprotein(a)

ReutersJun 20 07:30 ET

What Silence Therapeutics Plc's (NASDAQ:SLN) P/S Is Not Telling You

Simply Wall StMay 21 11:56 ET

6-K: Report of foreign private issuer (related to financial reporting)

SEC announcementMay 16 14:26 ET · Announcements

Express News | Corrected-Silence Therapeutics Files for Resale of up to 5.71 Mln American Depositary Shares (Not 'shares') by Selling Securityholders - SEC Filing

ReutersMay 7 18:20 ET

Express News | Silence Therapeutics PLC Files for Resale of up to 5.71 Mln Shares by the Selling Securityholders - SEC Filing

ReutersMay 7 17:04 ET

Silence Therapeutics Plc's (NASDAQ:SLN) Market Cap Touched US$1.1b Last Week, Benefiting Both Retail Investors Who Own 27% as Well as Institutions

Simply Wall StApr 22 08:01 ET

Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects With Elevated Lipoprotein(a)

Yahoo FinanceApr 8 11:48 ET

Analysts Are Upgrading Silence Therapeutics Plc (NASDAQ:SLN) After Its Latest Results

Yahoo FinanceMar 16 08:29 ET

Silence Therapeutics Plc (NASDAQ:SLN) Q4 2023 Earnings Call Transcript

Yahoo FinanceMar 15 11:56 ET

Recursion Pharmaceuticals (RXRX) Surges 13.8%: Is This an Indication of Further Gains?

Yahoo FinanceFeb 16 02:53 ET

Optimistic Investors Push Silence Therapeutics Plc (NASDAQ:SLN) Shares Up 26% But Growth Is Lacking

Simply Wall StFeb 3 07:00 ET

Insiders the Biggest Winners as Silence Therapeutics Plc's (NASDAQ:SLN) Market Cap Rises to US$736m

Simply Wall StJan 19 05:47 ET

All You Need to Know About Silence Therapeutics PLC Sponsored ADR (SLN) Rating Upgrade to Strong Buy

Yahoo FinanceJan 11 12:00 ET

Does Silence Therapeutics PLC Sponsored ADR (SLN) Have the Potential to Rally 187.05% as Wall Street Analysts Expect?

Yahoo FinanceDec 6, 2023 09:55 ET

Optimistic Investors Push Silence Therapeutics Plc (NASDAQ:SLN) Shares Up 65% But Growth Is Lacking

Simply Wall StNov 27, 2023 05:04 ET